[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 kilitli=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 arka plan_size=\u201dinitial\u201d arka plan_position=\u201dtop_left\u201d arka plan_repeat=\u201dtekrar\u201d global_colors_info=\u201d{ }\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201dcustom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.23.1\u2033header_2_font_size=\u201d24px\u201dheader_2_line_height=\u201d1.4em\u201dbackground_size=\u201dinitial\u201dbackground_position=\u201dtop_left\u201dbackground_repeat=\u201drepeat\u201dcustom_padding =\u201d25px||||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n
Lakeway, Teksas<\/b>\u00a0\u2013 Vigilant Biosciences, BeVigilant\u2122 OraFusion\u2122 Sisteminin In Vitro Tan\u0131 Y\u00f6netmeli\u011fi (IVDR) kapsam\u0131nda ba\u015far\u0131yla onayland\u0131\u011f\u0131n\u0131 duyurmaktan mutluluk duyar. Bu, uluslararas\u0131 b\u00fcy\u00fcme i\u00e7in \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131d\u0131r. Vigilant ayr\u0131ca T\u00fcrkiye, Malezya ve Tayland gibi \u00f6nemli pazarlarda da onay alm\u0131\u015ft\u0131r. Bu stratejik hamle, yakla\u015f\u0131k $15 milyarl\u0131k toplam pazar b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fcn kap\u0131lar\u0131n\u0131 a\u00e7arak, Vigilant'\u0131n h\u0131zla b\u00fcy\u00fcyen tan\u0131 sekt\u00f6r\u00fcndeki varl\u0131\u011f\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rmas\u0131n\u0131 sa\u011flayacakt\u0131r.<\/p>\n
BeVigilant OraFusion Sistemi, h\u0131zl\u0131 ve do\u011fru sonu\u00e7lar sunan, sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131n\u0131n bilin\u00e7li kararlar almas\u0131n\u0131 ve hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirmesini sa\u011flayan son teknoloji bir tan\u0131 arac\u0131d\u0131r. IVDR onay\u0131yla birlikte sistem, yenilik\u00e7i tan\u0131 \u00e7\u00f6z\u00fcmlerine olan talebin artmaya devam etti\u011fi bir\u00e7ok \u00f6nemli uluslararas\u0131 pazarda kullan\u0131ma sunulacakt\u0131r.<\/p>\n
Vigilant Biosciences CEO'su Bill Brodie, "OraFusion i\u00e7in IVDR onay\u0131 almaktan heyecan duyuyoruz," dedi. "Bu geni\u015fleme, k\u00fcresel \u00e7apta geli\u015fmi\u015f te\u015fhis \u00e7\u00f6z\u00fcmleri sunarken hayat kurtarma misyonumuzla \u00f6rt\u00fc\u015f\u00fcyor ve bu b\u00f6lgelerdeki hastalar i\u00e7in sa\u011fl\u0131k hizmetlerine eri\u015fim ve kaliteyi art\u0131r\u0131yor. Her y\u0131l 700.000'den fazla yeni a\u011f\u0131z kanseri vakas\u0131 te\u015fhis ediliyor ve bu, bir\u00e7ok pazarda \u00f6l\u00fcm oranlar\u0131nda art\u0131\u015f da dahil olmak \u00fczere d\u00fcnya \u00e7ap\u0131nda h\u0131zla b\u00fcy\u00fcyen birka\u00e7 kanser t\u00fcr\u00fcnden biri."\u00a0<\/p>\n
Uluslararas\u0131 pazarlara a\u00e7\u0131lma, sa\u011fl\u0131k sistemlerinin te\u015fhis yeteneklerini geli\u015ftirmeye giderek daha fazla odakland\u0131\u011f\u0131 bir d\u00f6nemde ger\u00e7ekle\u015fiyor. BeVigilant OraFusion Sistemi, \u00e7e\u015fitli sa\u011fl\u0131k ortamlar\u0131na uyarlanabilen g\u00fcvenilir test \u00e7\u00f6z\u00fcmleri sunarak, farkl\u0131 pop\u00fclasyonlar\u0131n ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamak \u00fczere tasarlanm\u0131\u015ft\u0131r.<\/p>\n
Vigilant, sa\u011fl\u0131k profesyonellerine ola\u011fan\u00fcst\u00fc hasta bak\u0131m\u0131 sunmalar\u0131 i\u00e7in ihtiya\u00e7 duyduklar\u0131 ara\u00e7lar\u0131 sa\u011flamay\u0131 taahh\u00fct etmektedir. \u015eirketin bu pazarlara a\u00e7\u0131lmas\u0131, yerel sa\u011fl\u0131k hizmeti sa\u011flay\u0131c\u0131lar\u0131na kapsaml\u0131 e\u011fitim ve destek sa\u011flayarak OraFusion sisteminin etkili bir \u015fekilde uygulanmas\u0131n\u0131 sa\u011flayacakt\u0131r.<\/p>\n
Vigilant, lansman\u0131na haz\u0131rlan\u0131rken, yerel distrib\u00fct\u00f6rler ve sa\u011fl\u0131k kurulu\u015flar\u0131yla ortakl\u0131klar kurmay\u0131 d\u00f6rt g\u00f6zle bekliyor. Bu i\u015f birli\u011fi, OraFusion sisteminin sorunsuz bir \u015fekilde piyasaya s\u00fcr\u00fclmesini kolayla\u015ft\u0131racak ve hem sa\u011fl\u0131k profesyonellerine hem de hastalara faydalar\u0131n\u0131 tan\u0131tacak.<\/p>\n
BeVigilant ve yenilik\u00e7i OraFusion sistemi hakk\u0131nda daha fazla bilgi i\u00e7in l\u00fctfen www.vigilantbiosciences.com adresini ziyaret edin.<\/p>\n
Dikkatli Biyolojik Bilimler<\/b> Vigilant, yenilik\u00e7i teknolojiler arac\u0131l\u0131\u011f\u0131yla hasta bak\u0131m\u0131n\u0131 iyile\u015ftirmeye kendini adam\u0131\u015f, geli\u015fmi\u015f tan\u0131 \u00e7\u00f6z\u00fcmlerinin lider sa\u011flay\u0131c\u0131s\u0131d\u0131r. Kalite, g\u00fcvenilirlik ve eri\u015filebilirli\u011fe odaklanan Vigilant, d\u00fcnya \u00e7ap\u0131ndaki sa\u011fl\u0131k profesyonellerini desteklemeye kendini adam\u0131\u015ft\u0131r.<\/p>\n
<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"
Lakeway, TX\u00a0\u2013 Vigilant Biosciences is pleased to announce the successful approval of its BeVigilant\u2122 OraFusion\u2122 System under the In Vitro Diagnostic Regulation (IVDR), marking a significant milestone for international expansion. Additionally, Vigilant received approval in key markets, including Turkey, Malaysia, and Thailand. This strategic move opens the doors to a combined market size of approximately […]<\/p>","protected":false},"author":9,"featured_media":810,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-808","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"\n